| Today's News and Trends | These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. These safety issues have been linked to more than 800 injuries and two deaths. It is possible, the FDA warned, that some patients may require a device to be removed and replaced. | | |
| The baby had been diagnosed with an especially challenging case of hypoplastic left heart syndrome. The baby had been diagnosed with an especially challenging case of hypoplastic left heart syndrome. | | |
| “Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. “Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. | | |
| The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over. The years-long shortage of Wegovy and Ozempic, two popular prescription-only semaglutide injections, is officially over. | | |
| | The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question. The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question. | | |
| James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology. James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology. | | |
| Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes. Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes. | | |
| The global medtech company is also looking to expand its organ transplant and ECMO portfolios. The global medtech company is also looking to expand its organ transplant and ECMO portfolios. | | |
| | These risks appear to be present regardless of a person's age or health at the time of infection. These risks appear to be present regardless of a person's age or health at the time of infection. | | |
| Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts. Female stroke survivors are less likely to receive a cardiology referral or undergo cardiac monitoring than their male counterparts. | | |
| The annual conference is now in its fourth year. Attendees are encouraged to leave their ties, jackets and skirts at home and embrace a more casual dress code. The annual conference is now in its fourth year. Attendees are encouraged to leave their ties, jackets and skirts at home and embrace a more casual dress code. | | |
| | Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts. Experts are interested in using computed tomography as an investigative tool due to its ability to provide detailed information while also preserving historical artifacts. | | |
| Xiaoqin Du, 63, of Suzhou, China, allegedly formed a rival firm in the same Chicago suburb as Philips, luring away engineers to relay intimate company details. Xiaoqin Du, 63, of Suzhou, China, allegedly formed a rival firm in the same Chicago suburb as Philips, luring away engineers to relay intimate company details. | | |
| |
|
| ![]() | |
|